News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,405 Results
Type
Article (2757)
Company Profile (8)
Press Release (94640)
Section
Business (39347)
Career Advice (77)
Deals (5687)
Drug Delivery (11)
Drug Development (11115)
Employer Resources (9)
FDA (1994)
Job Trends (2352)
News (55608)
Policy (3226)
Tag
Academia (175)
Accelerated approval (7)
Adcomms (3)
Allergies (28)
Alliances (3120)
ALS (24)
Alzheimer's disease (246)
Antibody-drug conjugate (ADC) (68)
Approvals (2154)
Artificial intelligence (35)
Autoimmune disease (21)
Bankruptcy (17)
Best Places to Work (2217)
Biosimilars (18)
Biotechnology (7)
Bladder cancer (47)
Brain cancer (9)
Breast cancer (146)
Cancer (921)
Cardiovascular disease (81)
Career advice (65)
Career pathing (4)
CAR-T (37)
Cell therapy (108)
Cervical cancer (7)
Clinical research (10600)
Collaboration (150)
Company closure (2)
Compensation (92)
Complete response letters (7)
COVID-19 (190)
CRISPR (16)
C-suite (38)
Cystic fibrosis (16)
Data (1353)
Depression (15)
Diabetes (83)
Diagnostics (904)
Digital health (5)
Diversity, equity & inclusion (3)
Drug discovery (21)
Drug pricing (36)
Duchenne muscular dystrophy (25)
Earnings (36538)
Editorial (1)
Employer resources (7)
Events (11751)
Executive appointments (53)
FDA (2725)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (1)
Frontotemporal dementia (9)
Funding (93)
Gene editing (27)
Generative AI (1)
Gene therapy (66)
GLP-1 (153)
Government (411)
Guidances (293)
Healthcare (2664)
HIV (12)
Huntington's disease (4)
IgA nephropathy (21)
Immunology and inflammation (30)
Immuno-oncology (7)
Indications (31)
Infectious disease (215)
Inflammatory bowel disease (19)
Inflation Reduction Act (1)
Influenza (8)
Intellectual property (18)
Interviews (11)
IPO (4169)
IRA (4)
Job creations (247)
Job search strategy (57)
JPM (4)
Kidney cancer (6)
Labor market (20)
Layoffs (51)
Legal (457)
Liver cancer (14)
Longevity (1)
Lung cancer (148)
Lymphoma (123)
Machine learning (2)
Management (3)
Manufacturing (70)
MASH (53)
Medical device (2159)
Medtech (2167)
Mergers & acquisitions (1631)
Metabolic disorders (235)
mRNA (10)
Multiple sclerosis (20)
NASH (4)
Neurodegenerative disease (45)
Neuropsychiatric disorders (11)
Neuroscience (410)
NextGen: Class of 2026 (695)
Non-profit (448)
Now hiring (5)
Obesity (94)
Opinion (17)
Ovarian cancer (28)
Pain (20)
Pancreatic cancer (28)
Parkinson's disease (42)
Partnered (5)
Patents (40)
Patient recruitment (55)
Peanut (14)
People (2665)
Pharmaceutical (3)
Pharmacy benefit managers (5)
Phase 1 (2461)
Phase 2 (4255)
Phase 3 (4613)
Pipeline (2155)
Policy (15)
Postmarket research (449)
Preclinical (720)
Press Release (4)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (46)
Rare diseases (122)
Real estate (339)
Recruiting (3)
Regulatory (3004)
Reports (13)
Research institute (205)
Resumes & cover letters (14)
Rett syndrome (3)
RNA editing (1)
RSV (8)
Schizophrenia (30)
Series A (9)
Series B (9)
Sickle cell disease (28)
Special edition (4)
Spinal muscular atrophy (15)
Sponsored (2)
Startups (165)
Stomach cancer (3)
Supply chain (5)
Tariffs (7)
The Weekly (1)
Vaccines (97)
Venture capital (6)
Weight loss (66)
Women's health (11)
Worklife (4)
Date
Last 7 days (101)
Last 30 days (577)
Last 365 days (5330)
2026 (1082)
2025 (5386)
2024 (6273)
2023 (6794)
2022 (10112)
2021 (10882)
2020 (9606)
2019 (6350)
2018 (4801)
2017 (4618)
2016 (3887)
2015 (4807)
2014 (3310)
2013 (1985)
2012 (2216)
2011 (2316)
2010 (2362)
Location
Africa (46)
Alabama (6)
Arizona (27)
Asia (4943)
Australia (556)
California (1988)
Canada (509)
China (176)
Colorado (92)
Connecticut (124)
Delaware (125)
Europe (12994)
Florida (255)
Georgia (67)
Hawaii (1)
Idaho (5)
Illinois (144)
India (6)
Indiana (119)
Japan (134)
Kansas (18)
Kentucky (8)
Louisiana (9)
Maine (43)
Maryland (247)
Massachusetts (1474)
Michigan (54)
Minnesota (85)
Mississippi (1)
Missouri (24)
Montana (4)
Nevada (9)
New Hampshire (10)
New Jersey (841)
New York (587)
North Carolina (233)
North Dakota (1)
Northern California (968)
Ohio (38)
Oregon (2)
Pennsylvania (395)
Rhode Island (2)
South America (118)
South Carolina (3)
Southern California (860)
Tennessee (18)
Texas (282)
United States (7446)
Utah (68)
Virginia (29)
Washington D.C. (16)
Washington State (180)
West Virginia (1)
Wisconsin (14)
97,405 Results for "34".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US
February 12, 2026
·
4 min read
Press Releases
SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
January 14, 2026
·
1 min read
Press Releases
Meloxicam Market Surpassed USD 12.34 Billion in 2032 Amid Rising Arthritis and Chronic Pain Cases
January 13, 2026
·
1 min read
Press Releases
NeuraLight and Teitur Trophics Announce Collaboration to Use Precision Biomarkers in TT-P34 Parkinson’s Disease Clinical Trial
January 22, 2026
·
3 min read
Press Releases
Morphine Drugs Market Size to Hit USD 34.89 Billion by 2034
November 21, 2025
·
1 min read
Press Releases
American Liver Foundation Hosts the 34th Annual Irwin M. Arias Symposium
December 2, 2025
·
7 min read
Press Releases
AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
January 9, 2026
·
2 min read
Press Releases
BOOST Pharma Adds Sound Bioventures to Investor Syndicate with SEK 34 Million Investment to Advance Stem Cell Therapy for Osteogenesis Imperfecta
November 3, 2025
·
2 min read
Press Releases
SpectronRx Accelerates Commercial Growth with Major Expansion of Its Grissom Aeroplex Manufacturing Campus
The 34-acre site now supports 200,000 square feet of GMP radiopharmaceutical production, with scalable capacity exceeding one million square feet
January 23, 2026
·
1 min read
1 of 9,741
Next
